Analyst Ratings for Nuvation Bio Inc (NUVB)
NUVB Rating Summary
NUVB Price Target Summary
- Highest: $20.00 (RBC Capital)
- Lowest: $6.00 (Wedbush)
- Average: $11.78
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.78 (+111.8%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
Avg. $ Target:
$11.78 (+111.8%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
12.00 (N/A) |
4.41 (5.56) |
26.08% | Details |
| 1/7/2026 | UBS » Updated 3/3/2026 |
Michael Yee | New Coverage | Neutral (N/A) |
7.00 (10.00) |
8.59 (5.56) |
-35.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
